<DOC>
	<DOCNO>NCT01095757</DOCNO>
	<brief_summary>The purpose study test whether addition drug plerixafor treatment chemotherapy G-CSF better activate bone marrow stem cell improve chance transplant . The study look activation certain type blood cell , call CD34+ cell patient receive plerixafor , chemotherapy G-CSF . The investigator follow number patient achieve target number CD34+ cell . The number patient achieve target level CD34+ cell , total number CD34+ cell , compare number previous study test chemotherapy G-CSF , without plerixafor . The investigator also test safety combination plerixafor chemotherapy G-CSF look success transplantation 12 month .</brief_summary>
	<brief_title>Evaluation Drug Plerixafor Combination With Chemotherapy G-CSF Stem Cell Collection</brief_title>
	<detailed_description />
	<mesh_term>JM 3100</mesh_term>
	<criteria>1 . Age 1870 year 2 . Multiple myeloma ( MM ) nonHodgkin 's lymphoma ( NHL ) patient first second complete partial remission 3 . Eastern Cooperative Oncology Group ( ECOG ) performance status 0 1 4 . Up 3 prior treatment regimens 5 . Meet eligibility requirement autologous transplant 6 . Adequate marrow function define white blood cell ( WBC ) &gt; 3,000 ; ANC &gt; 1,500/mm3 ; platelet &gt; 75,000/mm3 7 . Adequate renal function define creatinine clearance &gt; 30 mL/min CockcroftGault 8 . Adequate liver function define aspartate aminotransferase ( AST ) /alanine aminotransferase ( ALT ) /bilirubin &lt; 2 time upper limit normal 9 . Able provide inform consent 10 . Women pregnant agree use contraception 1 . High risk comorbidities acute treatment complication ( e.g. , symptomatic coronary artery disease ) 2 . Brain metastasis carcinomatous meningitis 3 . Previous treatment high dose chemotherapy autologous transplant 4 . Previous attempt collect Bhematopoietic progenitor cell ( HPCs ) follow mobilization growth factor alone , growth factor chemotherapy , plerixafor growth factor 5 . Acute infection unexplained fever &gt; 38Â°C 6 . Weight &gt; 175 % ideal body weight defined Devine equation 7 . Experimental therapy within 4 week 8 . Cytokine administration previous 14 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Myeloma</keyword>
	<keyword>Lymphoma</keyword>
	<keyword>Stem cell transplantation</keyword>
</DOC>